$2.74
In chiusura: Oct 6 EDT
$2.85
0.114.01%
Pre-mercato: 7:02 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Kiora Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 7
Stima EPS
$-0.720
Stima dei ricavi trimestrali
$750.00K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
–
Analizza lo storico degli utili di Kiora Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
KPRX | Kiora Pharmaceuticals | -$0.81 | -$0.72 | — | — | $0.00 | $750.00K | — | — | 11/07/2025 | |
KPRX | Kiora Pharmaceuticals | -$0.53 | -$0.58 | -$0.54 | 6.90% | $20.00K | $750.00K | $0.00 | -100.00% | 08/08/2025 | |
KPRX | Kiora Pharmaceuticals | $3.42 | -$0.77 | -$0.52 | 32.47% | $16.00M | $750.00K | $0.00 | -100.00% | 05/09/2025 | |
KPRX | Kiora Pharmaceuticals | $1.60 | -$0.70 | -$0.99 | -41.43% | $0.00 | $750.00K | $0.00 | -100.00% | 03/25/2025 | |
KPRX | Kiora Pharmaceuticals | -$8.01 | -$0.76 | -$0.81 | -6.58% | $0.00 | $10.00K | $0.00 | -100.00% | 11/08/2024 | |
KPRX | Kiora Pharmaceuticals | -$7.15 | -$0.81 | -$0.53 | 34.57% | $0.00 | — | $20.00K | — | 08/09/2024 | |
KPRX | Kiora Pharmaceuticals | -$9.00 | -$0.90 | $3.42 | 480.00% | $0.00 | — | $16.00M | — | 05/10/2024 | |
KPRX | Kiora Pharmaceuticals | -$31.59 | — | $1.60 | — | $0.00 | — | $0.00 | — | 03/25/2024 | |
KPRX | Kiora Pharmaceuticals | -$54.27 | -$3.15 | -$8.01 | -154.29% | $0.00 | — | $0.00 | — | 11/09/2023 | |
KPRX | Kiora Pharmaceuticals | -$64.80 | -$9.54 | -$7.11 | 25.47% | $0.00 | — | $0.00 | — | 08/08/2023 | |
KPRX | Kiora Pharmaceuticals | -$9.00 | -$15.12 | -$9.00 | 40.48% | $0.00 | — | $0.00 | — | 05/09/2023 | |
KPRX | Kiora Pharmaceuticals | -$280.80 | — | -$31.59 | — | $0.00 | — | $0.00 | — | 03/23/2023 | |
KPRX | Kiora Pharmaceuticals | -$104.40 | -$34.47 | -$39.15 | -13.58% | $0.00 | — | $0.00 | — | 11/09/2022 | |
KPRX | Kiora Pharmaceuticals | -$0.39 | — | -$64.80 | — | $0.00 | — | $0.00 | — | 08/12/2022 | |
KPRX | Kiora Pharmaceuticals | -$0.37 | — | -$97.20 | — | $0.00 | — | $0.00 | — | 07/08/2022 | |
KPRX | Kiora Pharmaceuticals | -$0.52 | — | -$280.80 | — | $12.06M | — | $0.00 | — | 04/15/2022 | |
KPRX | Kiora Pharmaceuticals | -$0.44 | — | -$104.40 | — | $0.00 | — | $0.00 | — | 11/15/2021 | |
KPRX | Kiora Pharmaceuticals | -$0.38 | -$0.42 | -$0.39 | 7.14% | $0.00 | — | $0.00 | — | 08/12/2021 | |
KPRX | Kiora Pharmaceuticals | -$0.43 | — | -$0.37 | — | $0.00 | — | $0.00 | — | 05/12/2021 | |
KPRX | Kiora Pharmaceuticals | -$0.76 | — | -$0.52 | — | $0.00 | — | $12.06M | — | 03/25/2021 | |
KPRX | Kiora Pharmaceuticals | -$1.15 | — | -$0.44 | — | $0.00 | — | $0.00 | — | 11/09/2020 |
Kiora Pharmaceuticals (KPRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $-0.54 | $-0.58 | 6.90 % |
| Q1 | 2025-05-09 | $-0.52 | $-0.77 | 32.5 % |
| Q4 | 2025-03-25 | $-0.99 | $-0.70 | -41.4 % |
| Q3 | 2024-11-08 | $-0.81 | $-0.76 | -6.58 % |
Kiora Pharmaceuticals (KPRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $0 | $750.00K | -100.0 % |
| Q1 | 2025-05-09 | $0 | $750.00K | -100.0 % |
| Q4 | 2025-03-25 | $0 | $750.00K | -100.0 % |
| Q3 | 2024-11-08 | $0 | $10.00K | -100.0 % |
FAQ
Quando Kiora Pharmaceuticals (NASDAQ:KPRX) riporterà gli utili?
Si prevede che Kiora Pharmaceuticals (KPRX) fornisca risultati il novembre 7, 2025. Gli ultimi risultati sono stati pubblicati il agosto 8, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Kiora Pharmaceuticals (NASDAQ:KPRX)?
L'EPS effettivo era $-0.54, che superato la stima di $-0.58.
Quali sono state le entrate di Kiora Pharmaceuticals (NASDAQ:KPRX)?
Le entrate effettive sono state $0K, che mancato la stima di $750K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.